Neurocrine Bio. (NBIX) PT Lowered to $177 at JPMorgan
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.39 +1.04%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $177.00 (from $179.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Lowered to $182 at Morgan Stanley
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
